Clinical trials: Thin-cap fIbroatheroma
Coronary Artery Disease, Thin-cap fIbroatheroma
The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography
the purpose of this study is to show that alirocumab with statin therapy have a s tronger stabilizing effect on vulnerable plaque in coronary artery disease than statin alone administration
- Trial name
- ALTAIR (NCT03552432)
- Testing
- Alirocumab
- Where
- Japan
- Volunteers
- 24 people
- Sponsor
- Kobe University